Since it is year-end, we wanted to compile a list of the 2008 likely Dogs of the Dow. We included Friday’s closing prices for each DJIA component and we also gave the…
According to Reuters, Oracle (ORCL) posted strong earnings and offered a robust outlook for its business. Reuters writes that Barclays (BCS) has sued Bear Stearns (BSC) over losses in two hedge funds…
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks and the businesses haven’t turned around. Could these be the stocks to…
Biogen-Iden (NASDAQ:BIIB) is seeing its shares pummeled in after-hours trading. The company didn’t have another biotech drug crisis though. Biogen had been under a corporate strategic review where it was evaluating strategic…
It is always interesting seeing which groups and which stocks saw the biggest changes in short interest. This list doesn’t show financials because we’ve already shown that individually. Here are some of…
According to Reuters, the Fed’s decision to make an October rate cute was a "close call." Reuters writes that Paulson said home loan defaults will be much higher in 2008. Reuters writes…
Pfizer (NYSE:PFE) is seeing additional pressure this afternoon. Apparently the FDA said it is looking into reports that Pfizer has sent out an "early communications notice" to doctors warning them to monitor…
According to Reuters, Goldman Sachs (GS) issued a report saying the housing sector had much further to fall and that some financial institutions would have to raise money to stay in business.…
We have already noted the Van der Moolen (NYSE:VDM) exit of all NYSE Specialist activities and we’ve already covered some of the other key stocks where Van der Moolen acts as a…
Pfizer (PFE) has a new ad campaign for its erectile dysfunction drug Viagra. The marketing message is all over TV and in little video clips online. Reuters.com appears to have one of…
Douglas A. McIntyre Following is the short interest in stocks of major companies traded on the NYSE. Figures are as of October 15 and compare to numbers on September 28, 2007. Most of the large…
IMS Health (RX) Bad numbers and a downgrade. Falls to $21.20 from 52-week high of $33.12. The PMI Group (PMI) Housing and mortgage markets hurt quarter. Falls to $22.80 from 52-week high…
Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would end its involvement in inhaled diabetes drug Exubera and return the licensing…
Pfizer (PFE) posted third-quarter 2007 revenues of $12.0 billion, a 2% decline from the same period last year. The Company’s reported net income was $761 million in the third quarter of 2007,…
Douglas A. McIntyre Pfizer (PFE) is hooking up with doctor social network Sermo. According to The Wall Street Journal: "Pfizer-affiliated doctors will be able to talk candidly with the site’s 31,000 members, potentially giving the…
Douglas A. McIntyre 